Autoantibody Seromics Overview

Autoantibodies play a crucial role in the development and progression of autoimmune diseases which occur when the immune system mistakenly targets and attacks the body's own tissues, mistaking them for foreign invaders.

Autoantibodies can directly contribute to tissue damage in conditions like rheumatoid arthritis and systemic lupus erythematosus, where autoantibodies target joint tissues or components of the skin, kidneys, and other organs, leading to inflammation and organ dysfunction. They can even directly influence the function of immune cytokines, altering the progression and symptoms of autoimmune conditions.

Understanding the specific autoantibodies involved in an autoimmune disease can guide treatment strategies. For example, therapies may aim to suppress the overall immune response, reduce inflammation, or target specific components of the immune system responsible for producing autoantibodies.

Research in the field of autoimmunity is ongoing, and scientists are continually identifying new autoantibodies associated with different autoimmune diseases. This deeper understanding of the role of autoantibodies is contributing to the development of more targeted and personalized approaches to the diagnosis and treatment of autoimmune conditions.

> Contact us about your autoimmune disease study or questions.

Autoantibodies can play a significant role in neurological diseases, contributing to various autoimmune disorders that affect the central nervous system. In these conditions, the immune system mistakenly targets components of the nervous system, leading to inflammation, tissue damage, and neurological symptoms.

The detection of specific autoantibodies in the blood or cerebrospinal fluid can aid in the diagnosis of certain neurological diseases and is often performed in conjunction with clinical and imaging studies to confirm diagnoses.

Conditions for which autoantibodies have been indicated as a causal factor include, Autoimmune Encephalitis, Paraneoplastic Neurological Syndromes, Multiple Sclerosis, Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy.

> Contact us about your neurological disease study or questions.

While many genetic conditions are not explicitly thought of as immunologic disorders, it is impossible to separate the immune system from the rest of the human body. Due to the inherently interconnected nature of living systems, even a simple perturbation in the function of most any cell type or metabolic process is likely to have complex cascading effects that ripple and alter the behavior of other bodily systems. The adaptive immune system in particular, representing approximating half of all nucleated cells in the human body, has behavior that is particularly sensitive to genetic dysregulation. These effects can create over-active immunity with increased rates of autoimmune and inflammatory disease, or under-active immunity that makes the affected patients more susceptible to infection.

The genetic conditions causing this can be simple, affecting a single gene. Alternatively, they can be very complex such as the case of Down Syndrome, where the presence of an extra chromosome 21 creates altered expression for hundreds of genes simultaneously. In most cases the health of affected patients remains closely linked to properly controlled immune behavior: successful disease clearance, tolerance to foods and allergens, avoidance of autoimmunity, and successful cancer immunosurveillance.

Genetic impacts can be felt in immune cells directly, with mutations in immune-expressed genes resulting in altered metabolism and responses to immune signaling pathways. Alternatively, genetic defects can primarily alter the behavior of other somatic cells, altered behavior that can disrupt how those tissues are able to successfully recruit inflammation or prevent autoimmunity.

> Contact us about your genetic disease study or questions.